A comparative study of dexmedetomidine combined with esketamine and sufentanil for sedation and analgesia in patients undergoing microwave ablation of lung tumors: A prospective single-center randomized double-blind clinical trial
Esketamine plus dexmedetomidine demonstrated potential advantages for lung tumor MWA compared to sufentanil plus dexmedetomidine.
Authors
- Ying Zhang (ORCID: https://orcid.org/0000-0002-6528-656X)
- Yue Li (ORCID: https://orcid.org/0000-0001-6924-8969)
- Yanan Zhang (ORCID: https://orcid.org/0000-0001-9350-9444)
- Yanhua Chen (ORCID: https://orcid.org/0000-0002-5241-258X)
- Yuxia Li (ORCID: https://orcid.org/0000-0002-2740-8538)
- Yubo Xie (ORCID: https://orcid.org/0000-0002-8393-6335)
- Guofeng Liu (ORCID: https://orcid.org/0009-0001-6494-7119)
- Nuo Yang (ORCID: https://orcid.org/0009-0002-1336-878X)
- Jianji Guo
Institutions
- First Affiliated Hospital of GuangXi Medical University (CN)
Publication Details
- Journal
- Journal of Cancer Research and Therapeutics
- Published
- 2025-09-01
- DOI
- https://doi.org/10.4103/jcrt.jcrt_2214_24
- Primary Topic
- Anesthesia and Sedative Agents
- Type
- article
- Field-Weighted Citation Impact
- 0.00